34 related articles for article (PubMed ID: 14616449)
1. Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition.
Cheng TS; Noor U; Watts E; Pollak M; Wang Y; McKay J; Atkins J; Masala G; Sánchez MJ; Agudo A; Castilla J; Aune D; Colorado-Yohar SM; Manfredi L; Gunter MJ; Pala V; Josefsson A; Key TJ; Smith-Byrne K; Travis RC
BMC Cancer; 2024 Jun; 24(1):676. PubMed ID: 38831273
[TBL] [Abstract][Full Text] [Related]
2. Effects of natural extract interventions in prostate cancer: A systematic review and network meta-analysis.
Huang H; Qin J; Wen Z; Liu Y; Chen C; Wang C; Li H; Yang X
Phytomedicine; 2024 Jul; 129():155598. PubMed ID: 38608596
[TBL] [Abstract][Full Text] [Related]
3. The relevance of circRNAs in serum of patients undergoing prostate biopsy.
Samirae L; Krausewitz P; Alajati A; Kristiansen G; Ritter M; Ellinger J
Int J Urol; 2024 May; 31(5):578-580. PubMed ID: 38363018
[No Abstract] [Full Text] [Related]
4. The relevance of circRNAs in serum of patients undergoing prostate biopsy.
Urabe F
Int J Urol; 2024 May; 31(5):581. PubMed ID: 38469670
[No Abstract] [Full Text] [Related]
5. The Protective Effect of Lycopene on Prostate Growth Inhibitory Efficacy by Decreasing Insulin Growth Factor-1 in Indonesian Human Prostate Cancer Cells.
Tjahjodjati ; Sugandi S; Umbas R; Satari M
Res Rep Urol; 2020; 12():137-143. PubMed ID: 32368526
[TBL] [Abstract][Full Text] [Related]
6. Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target.
Liu G; Zhu M; Zhang M; Pan F
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831629
[TBL] [Abstract][Full Text] [Related]
7. Association between serum levels of insulin-like growth factor-1, bioavailable testosterone, and pathologic Gleason score.
Kim M; Kim JW; Kim JK; Lee SM; Song C; Jeong IG; Hong JH; Kim CS; Ahn H
Cancer Med; 2018 Aug; 7(8):4170-4180. PubMed ID: 29992746
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and prostate cancer: correlation with Gleason score.
Correa LL; Neto LV; Lima GA; Gabrich R; Miranda LC; Gadelha MR
Int Braz J Urol; 2015; 41(1):110-5. PubMed ID: 25928516
[TBL] [Abstract][Full Text] [Related]
9. Examining the relationship between obesity and prostate cancer.
Freedland SJ; Aronson WJ
Rev Urol; 2004; 6(2):73-81. PubMed ID: 16985580
[TBL] [Abstract][Full Text] [Related]
10. Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence.
Yu H; Nicar MR; Shi R; Berkel HJ; Nam R; Trachtenberg J; Diamandis EP
Urology; 2001 Mar; 57(3):471-5. PubMed ID: 11248622
[TBL] [Abstract][Full Text] [Related]
11. IGF-I, insulin and prostate cancer.
Lima GA; Corrêa LL; Gabrich R; Miranda LC; Gadelha MR
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):969-75. PubMed ID: 20126849
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies.
Chan JM; Stampfer MJ; Giovannucci E; Ma J; Pollak M
Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S32-3. PubMed ID: 10984284
[No Abstract] [Full Text] [Related]
13. Serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 do not correlate with Gleason score or quantity of prostate cancer in biopsy samples.
Ismail HA; Pollak M; Behlouli H; Tanguay S; Bégin LR; Aprikian AG
BJU Int; 2003 Nov; 92(7):699-702. PubMed ID: 14616449
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy.
Ismail A H; Pollak M; Behlouli H; Tanguay S; Begin LR; Aprikian AG
J Urol; 2002 Dec; 168(6):2426-30. PubMed ID: 12441932
[TBL] [Abstract][Full Text] [Related]
15. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D
Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
